“…The authors reported the frequencies of PTC and undifferentiated thyroid cancer were 6% and 2%, respectively, among all patients (14). The possibility of concurrence of HT, PTC, and MTC depends on some gene rearrangements (5,6,9,13). Besides these synchronous occurrences, HT has been introduced as playing a protective role against PTC progression (15).…”